Vestor Capital LLC grew its holdings in shares of SPDR S&P Biotech (NYSEARCA:XBI) by 0.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,663 shares of the exchange traded fund’s stock after buying an additional 208 shares during the quarter. Vestor Capital LLC’s holdings in SPDR S&P Biotech were worth $2,984,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in XBI. Papp L Roy & Associates lifted its position in shares of SPDR S&P Biotech by 3.1% during the second quarter. Papp L Roy & Associates now owns 187,538 shares of the exchange traded fund’s stock worth $14,474,000 after purchasing an additional 5,648 shares in the last quarter. Main Management LLC lifted its position in shares of SPDR S&P Biotech by 0.7% during the second quarter. Main Management LLC now owns 146,360 shares of the exchange traded fund’s stock worth $11,296,000 after purchasing an additional 978 shares in the last quarter. Polaris Greystone Financial Group LLC lifted its position in shares of SPDR S&P Biotech by 1.4% during the second quarter. Polaris Greystone Financial Group LLC now owns 132,336 shares of the exchange traded fund’s stock worth $10,214,000 after purchasing an additional 1,866 shares in the last quarter. Weatherly Asset Management L. P. lifted its position in shares of SPDR S&P Biotech by 4.5% during the second quarter. Weatherly Asset Management L. P. now owns 125,537 shares of the exchange traded fund’s stock worth $9,689,000 after purchasing an additional 5,374 shares in the last quarter. Finally, SG Americas Securities LLC lifted its position in shares of SPDR S&P Biotech by 252.0% during the second quarter. SG Americas Securities LLC now owns 115,516 shares of the exchange traded fund’s stock worth $8,916,000 after purchasing an additional 82,698 shares in the last quarter.

TRADEMARK VIOLATION WARNING: This piece was published by Daily Political and is the sole property of of Daily Political. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.dailypolitical.com/2017/09/13/vestor-capital-llc-grows-holdings-in-spdr-sp-biotech-xbi.html.

SPDR S&P Biotech (NYSEARCA:XBI) traded up 0.3884% on Wednesday, hitting $83.8444. 520,095 shares of the stock were exchanged. The company’s 50 day moving average price is $79.12 and its 200-day moving average price is $73.64. SPDR S&P Biotech has a one year low of $53.15 and a one year high of $84.90.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.